Literature DB >> 6612996

Analysis of Ad5 hexon and 100K ts mutants using conformation-specific monoclonal antibodies.

C L Cepko, P A Sharp.   

Abstract

Adenovirus type 5 ts mutants deficient in hexon metabolism were investigated using conformation-specific monoclonal antibodies directed against hexon capsomeres and the viral 100K protein. The ts mutants map either in the hexon structural gene or in the gene encoding the 100K protein, a major, late nonstructural protein. All of the mutants examined (ts1, ts2, ts3, ts4, ts17, and ts20 of J. F. Williams, M. Gharpure, S. Ustacelebi, and S. McDonald (1971). J. Gen. Virol. 11, 95-101) were unable to produce the capsomeric form of hexon (a trimer of three hexon monomers) at the nonpermissive temperature. However, all of the mutants retained the ability to produce a complex of 100K and hexon which has been demonstrated to play a major role in the assembly of hexon trimers. The mutants accumulated nontrimerized hexon in this ts complex in the perinuclear region of the cell. Several of the mutants (ts1, ts2, ts3) were found to successfully assemble hexon synthesized at the nonpermissive temperature upon shift down to the permissive temperature, even in the presence of a protein synthesis inhibitor. The mutant, ts2, which maps in the hexon structural gene, was found to be dependent on protein synthesis for transport of hexon trimers into the nucleus during temperature shift down, while the 100K ts mutants, ts1 and ts3, were independent of protein synthesis for both hexon assembly and transport.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6612996     DOI: 10.1016/0042-6822(83)90402-6

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

1.  Adenovirus vectors with the 100K gene deleted and their potential for multiple gene therapy applications.

Authors:  B L Hodges; H K Evans; R S Everett; E Y Ding; D Serra; A Amalfitano
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  CRM1-dependent transport supports cytoplasmic accumulation of adenoviral early transcripts.

Authors:  Melanie Schmid; Ramon A Gonzalez; Thomas Dobner
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

3.  Critical role for arginine methylation in adenovirus-infected cells.

Authors:  Demetris C Iacovides; Clodagh C O'Shea; Juan Oses-Prieto; Alma Burlingame; Frank McCormick
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

4.  Cytomegalovirus assembly protein precursor and proteinase precursor contain two nuclear localization signals that mediate their own nuclear translocation and that of the major capsid protein.

Authors:  S M Plafker; W Gibson
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  The adenovirus L4 100-kilodalton protein is necessary for efficient translation of viral late mRNA species.

Authors:  B W Hayes; G C Telling; M M Myat; J F Williams; S J Flint
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  Characterization of group II avian adenoviruses with a panel of monoclonal antibodies.

Authors:  J V van den Hurk; S van Drunen Littel-van den Hurk
Journal:  Can J Vet Res       Date:  1988-10       Impact factor: 1.310

7.  Functional dissection of adenovirus VAI RNA.

Authors:  M R Furtado; S Subramanian; R A Bhat; D M Fowlkes; B Safer; B Thimmappaya
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

8.  RNA-binding properties of a translational activator, the adenovirus L4 100-kilodalton protein.

Authors:  D Riley; S J Flint
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

9.  Structure of the herpesvirus major capsid protein.

Authors:  Brian R Bowman; Matthew L Baker; Frazer J Rixon; Wah Chiu; Florante A Quiocho
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

10.  Protein arginine methylation during lytic adenovirus infection.

Authors:  Julia Kzhyshkowska; Elisabeth Kremmer; Markus Hofmann; Hans Wolf; Thomas Dobner
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.